#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Conjunctivitis allergic Herpes simplex Rhabdomyosarcoma recurrent Lymphangiosarcoma Mantle cell lymphoma refractory Neuromyelitis optica spectrum disorder Familial amyotrophic lateral sclerosis Dementia Alzheimer's type Extra-osseous Ewing's sarcoma recurrent Orthostatic hypotension Neuropathy peripheral Richter's syndrome Pulmonary fibrosis Vaginal cancer Anal fistula More trials…

    Learn about Rare Diseases

    Nephroblastoma – Diagnostics Gaucher’s disease type III – Basic Information Rosai-Dorfman syndrome – Basic Information Pelizaeus-Merzbacher disease – Diagnostics Langerhans cell sarcoma Shprintzen-Goldberg syndrome – Diagnostics Advanced systemic mastocytosis – Treatment Hereditary motor and sensory neuropathy – Treatment Alveolar rhabdomyosarcoma – Treatment Propionic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Exemestane Nizaracianine Triflutate Rbp030.2 Carcik-Cd19 Cells Sargramostim Ampicillin Fusidic Acid Naxitamab Ofloxacin Nitric Oxide Gindameran Hydroxypropylbetadex GSK5458514 Zimberelimab Prednisolone Acetate GOVORESTAT Teropavimab Simvastatin GRAPHITE Vobramitamab Duocarmazine More therapies…

    Learn about Your Condition

    Bacteraemia Mantle cell lymphoma stage IV Acute HIV infection Primary hypogonadism Microvillous inclusion disease Altered state of consciousness Renal injury Irritable bowel syndrome Cholangitis sclerosing Type 2 diabetes mellitus Post procedural swelling Hypercholesterolaemia Right ventricular dysfunction Frontotemporal dementia Lip and/or oral cavity cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of NX-5948 in adults with relapsed or resistant chronic lymphocytic leukemia and small lymphocytic lymphoma who previously received BTK inhibitor and BCL-2 inhibitor treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia refractory
    • B-cell small lymphocytic lymphoma
    France Hungary Italy Poland

  • Study of NVD003 stem cell implant compared to bone graft for children with congenital pseudarthrosis of the tibia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Autologous Adipose-Derived Stem Cells
    Belgium France Spain

  • Study evaluating HER2DX-guided treatment in patients with early-stage HER2-positive breast cancer using trastuzumab, pertuzumab and combination chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Epirubicin
    • Cyclophosphamide
    • Docetaxel
    France Germany Ireland Spain

  • Study of intestinal gel containing levodopa, carbidopa and entacapone to treat motor and behavioral symptoms in patients with Parkinson’s disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Levodopa
    Germany

  • Study of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia

    Recruiting

    4 1
    Investigated Drugs:
    • Efgartigimod Alfa
    France Germany Hungary Italy Lithuania Poland +2

  • Study of inhaled aprotinin for treatment of moderate to severe acute respiratory distress syndrome

    Recruiting

    3 1
    Investigated Drugs:
    • APROTININ
    Spain
Previous Page
1 … 150 151 152 153 154 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!